Vytrus Biotech Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Vytrus Biotech.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Personal Products earnings growth | 8.4% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 07 Aug 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 5 | N/A | N/A | N/A | 1 |
12/31/2023 | 5 | 1 | 0 | 1 | N/A |
9/30/2023 | 5 | 1 | 0 | 1 | N/A |
6/30/2023 | 5 | 1 | -1 | 0 | N/A |
3/31/2023 | 5 | 1 | 0 | 0 | N/A |
12/31/2022 | 4 | 1 | 0 | 1 | N/A |
9/30/2022 | 4 | 1 | 0 | 1 | N/A |
6/30/2022 | 4 | 1 | 0 | 0 | N/A |
3/31/2022 | 4 | 1 | 0 | 0 | N/A |
12/31/2021 | 4 | 0 | 0 | 0 | N/A |
12/31/2020 | 2 | 0 | 0 | 0 | N/A |
12/31/2019 | 2 | 0 | N/A | N/A | N/A |
12/31/2018 | 1 | 0 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if V5P's forecast earnings growth is above the savings rate (0.8%).
Earnings vs Market: Insufficient data to determine if V5P's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if V5P's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if V5P's revenue is forecast to grow faster than the German market.
High Growth Revenue: Insufficient data to determine if V5P's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if V5P's Return on Equity is forecast to be high in 3 years time